These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2169517)

  • 21. Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines.
    Raney AK; Milich DR; Easton AJ; McLachlan A
    J Virol; 1990 May; 64(5):2360-8. PubMed ID: 2157890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning and characterization of the cDNA coding for hepatitis B virus surface antigen.
    He BG; Melnick JL; Siddiqui A; Robinson WS; Law SW; Lai EC
    Sci Sin B; 1985 Jan; 28(1):49-59. PubMed ID: 2984765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. State of hepatitis B viral DNA in a human hepatoma cell line.
    Marion PL; Salazar FH; Alexander JJ; Robinson WS
    J Virol; 1980 Feb; 33(2):795-806. PubMed ID: 6251250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of hepatitis B surface antigen in human hepatoma-derived cell lines.
    Oefinger PE; Bronson DL; Dreesman GR
    J Gen Virol; 1981 Mar; 53(Pt 1):105-13. PubMed ID: 6268737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of receptors for polymerized albumin in HBsAg-containing hepatocytes and hepatoma cell line.
    Thung SN; Gerber MA
    Hepatology; 1981; 1(2):132-6. PubMed ID: 6269978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of alpha, beta and gamma human interferons on a HBsAg-producing human hepatoma cell line.
    Manzin A; Bagnarelli P; Brugia M; Pauri P; Clementi M
    Ric Clin Lab; 1986; 16(3):457-62. PubMed ID: 2433727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latent hepatitis B virus (HBV) infection and HBV DNA integration is associated with further transformation of hepatoma cells in vitro.
    Favre D; Petit MA; Trépo C
    ALTEX; 2003; 20(3):131-42. PubMed ID: 12947486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies by immune electron microscopy of hepatitis B surface antigen in PLC/PRF/5 cells.
    Shibayama T; Watanabe T; Kojima H; Yoshikawa A; Watanabe S; Kamimura T; Suzuki S; Ichida F
    J Med Virol; 1984; 13(3):205-14. PubMed ID: 6327897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytochemical investigation of hepatitis B virus-associated antigens in cases of liver cirrhosis and HBsAg antigenemia and their relationship to development of hepatocellular carcinoma.
    Iwai M; Kashiwadani M; Okuno T; Takino T; Ibata Y
    Histochem J; 1988 May; 20(5):283-9. PubMed ID: 2850288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus components produced by the human hepatoma cell line PLC/PRF/5: do they indicate virus propagation? Brief review.
    Marquardt O
    Arch Virol; 1986; 90(1-2):1-14. PubMed ID: 3015073
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis B surface antigen produced by a human hepatoma cell line.
    MacNab GM; Alexander JJ; Lecatsas G; Bey EM; Urbanowicz JM
    Br J Cancer; 1976 Nov; 34(5):509-15. PubMed ID: 187208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of viral replication in HBsAg positive patients with hepatocellular carcinoma: measurement of serum hepatitis B virus deoxyribonucleic acid (HBV-DNA).
    Guan R; Yap I; Wong L; Tan LH; Oon CJ; Wee A
    Ann Acad Med Singap; 1989 Jan; 18(1):8-11. PubMed ID: 2540692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease.
    Chemin I; Jeantet D; Kay A; Trépo C
    Antiviral Res; 2001 Nov; 52(2):117-23. PubMed ID: 11672821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell.
    Edman JC; Gray P; Valenzuela P; Rall LB; Rutter WJ
    Nature; 1980 Jul; 286(5772):535-8. PubMed ID: 6250075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural analysis of hepatitis B surface antigen production in vitro.
    Aoki N; Thung SN; Gerber MA
    Lab Invest; 1982 Nov; 47(5):465-70. PubMed ID: 6182389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
    Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH
    Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity.
    Kessler HA; Pottage JC; Trenholme GM; Benson CA; Levin S
    AIDS Res; 1986 Feb; 2(1):63-72. PubMed ID: 2424468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.
    Song J; Zhang X; Ge Q; Yuan C; Chu L; Liang HF; Liao Z; Liu Q; Zhang Z; Zhang B
    J Cell Biochem; 2018 Nov; 119(10):8419-8431. PubMed ID: 29904948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I; Willems A; Gijbels Y; Leroux-Roels G
    J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunometric assay for hepatitis B surface antigen on the surface of infected cells.
    Fukusato T; Thung SN; Gerber MA
    J Immunol Methods; 1984 Dec; 75(2):325-32. PubMed ID: 6097612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.